GSL Biotech, LLC
Part of Graphpad Software, LLC
- UEI
- M78LBLFHT5S4
- CAGE
- 48VC1
- Primary NAICS
- 513210 Software Publishers
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- Other NAICS codes in SAM.gov
- Corporate family
-
-
Parent
Boston, MA
NH43R2NEKRC8
-
Parent
Boston, MA
NH43R2NEKRC8
- SAM.gov registration date
- Website
- snapgene.com
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Information Technology
- Software & Services
- Internet Software & Services
- SIC code
- 73 Business Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $16,200 |
| FY2024 | $40,164 |
| FY2023 | $41,690 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Software to facilitate DNA cloning | National Institutes of Health | $750,000 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Dnastar, Inc. | Madison, WI | 513210 Software Publishers |
| Biomatters LIMITED | — | — |
| Sentieon Inc. | San Jose, CA | 513210 Software Publishers |
| Genedata (Usa), Inc. | Lexington, MA | 513210 Software Publishers |
| C M Cherry Consulting LLC | Baltimore, MD | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
About the company
GSL Biotech, LLC, doing business as Snapgene, is a self-certified small disadvantaged business registered in SAM.gov since December 2005. The company specializes in developing advanced molecular biology software that provides researchers with tools for DNA and RNA sequence analysis, assembly, and annotation. Snapgene's software is designed to support scientific research by offering intuitive platforms for molecular cloning, experimental design, and data visualization, which has made it a valuable resource for biomedical research institutions.
The company has consistently secured federal contract awards from multiple National Institutes of Health (NIH) agencies, including the National Institute of Environmental Health Sciences, National Institute of Child Health and Human Development, National Heart, Lung and Blood Institute, and the National Cancer Institute. These awards are primarily structured as firm fixed-price purchase orders for annual software subscriptions, ranging from $10,200 to $22,000, with various user activation levels (10-175 concurrent seats). The contracts are predominantly for Snapgene academic yearly subscriptions and network licenses, supporting researchers across different institutes by providing software tools for molecular biology procedures. No set-aside designations have been used in these contract awards, and the contracts are consistently classified as purchase orders for software and academic license renewals, demonstrating the company's specialized focus on providing critical research software to federal scientific organizations.
SBA capabilities narrative
SnapGene provides the easiest and most secure way to plan, visualize, and document your everyday molecular biology procedures. SnapGene makes your DNA manipulations easy to visualize and simulate and alerts you to errors before they happen. SnapGene's. DNA files can be opened by the free cross-platform SnapGene Viewer, enabling you to share richly annotated maps and sequences with colleagues. SnapGene automatically generates a record of every sequence edit and cloning procedure, so you will not lose track of how a construct was made, even after a lab member leaves.
Quick answers
Is GSL Biotech, LLC registered in SAM.gov?
GSL Biotech, LLC's SAM.gov registration expired on January 14, 2026.
How much has GSL Biotech, LLC received in federal contracts?
Federal contracts obligated $16,200 to GSL Biotech, LLC in fiscal year 2025 and $98,054 in fiscal years 2023 through 2027.
What is GSL Biotech, LLC's most recent federal award?
GSL Biotech, LLC's most recent federal contract award is [25-003999] nhlbi information technology applications center (itac) & nhlbi scientific information office (SIO) would… (75N92025P00036), from National Heart Lung and Blood Institute (NIH), on December 15, 2024.
On GovTribe
See GSL Biotech, LLC's full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors